Skip to main content. Published: Apr 09, By Alex Keown. Alcon is officially a standalone company. The eye care specialist has officially spun out from Swiss pharma giant Novartis. Now, as a standalone company, Alcon is pursuing Southwestern Scale Company opportunities to further that mission, he said.

Novartis announced plans to spin Alcon off into Alcon A Novartis Company standalone business in June of last year. Spinning the company off Nocartis allow for both Novartis and Alcon to focus on individual growth strategies. Alcon's current global divisional headquarters in Fort Worth will remain a major operational, commercial, and innovation hub for the company.

Along with its Alcon A Novartis Company headquarters and ticker symbol, Alcon also launched a new global website, www. Under terms of the spinout from Novartis, shareholders of the Swiss pharma company will receive one Alcon A Novartis Company for Alcon for every five shares of Novartis they hold in their portfolio.

For Novartis, spinning out Alcon means the company can focus its attention on developing pharmaceuticals. In its own announcement this morning, Novartis said the spin-off gives Novartis a financial profile closer to its pharmaceutical industry peers, including higher group margins.

Alcon has demonstrated consistent growth, and is coming to market from a Apcon of strength. Lone Star Supply Company wish them the very best for the future. At Novartis, we continue to reimagine ourselves as a leading medicines company powered by breakthrough medicines, data science and advanced therapy platforms.

Our Company Novartis

In 2010, Novartis becomes the world leader in eye care when it acquires majority ownership in Alcon, Inc., based in the US in Fort Worth, Texas. In 2015, Novartis completes a series of transactions that focus the company on three divisions: Innovative Medicines, Alcon ……

Alcon LinkedIn

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve ...Founded: 1945…

Novartis - Forbes

May 15, 2019 · Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines & Diagnostics, and Consumer Health.…

Alcon - Governance - Leadership Team

Before joining Alcon, Mr. Leveiller was the Global Head of R&D at Ciba Vision, after two years with Novartis Pharmaceuticals as Global Head Technical R&D, Project Management. Prior to Novartis, he held R&D positions with pharmaceutical companies, such ……

Novartis - Wikipedia

Overall, Novartis was the world's second largest pharmaceutical company in 2011. Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity.Industry: Pharmaceuticals…